Dutasteride 13C6
| Product Name | Dutasteride 13C6 |
|---|---|
| Alternate Names | Dutasteride Stable Isotopes, Stable Isotopes of Dutasteride |
| CAT No. | CS-O-02980 |
| CAS No. | 1217685-27-2 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 534.49 g/mol |
| Mol. For. | C₂₁¹³C₆H₃₀F₆N₂O₂ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Dutasteride |
| Purity | 95% |
| Smileys | C[C@@]1([C@H]2C(N[13C]([13CH]=[13C](C(F)(F)F)[13CH]=[13CH]3)=[13C]3C(F)(F)F)=O)[C@](CC2)([H])[C@@](CC[C@](N4)([H])[C@@]5(C=CC4=O)C)([H])[C@]5([H])CC1 |
| Canonical Smiles | CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C |
| InchIKey | JWJOTENAMICLJG-JADBXJRRSA-N |
| Inchl | InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1/i3+1,5+1,13+1,14+1,18+1,20+1 |
| IUPAC | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-trien-1-yl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Dutasteride 13C6 is a medication that is primarily used to treat symptoms of an enlarged prostate gland, a condition known as benign prostatic hyperplasia (BPH). It works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone that is responsible for the growth of the prostate gland. This results in a reduction of the size of the prostate gland, which in turn helps to alleviate symptoms such as difficulty urinating, frequent urination, and urinary urgency.
Chemically, Dutasteride 13C6 is a synthetic 4-azasteroid compound that is structurally similar to finasteride, another medication used for the treatment of BPH. However, Dutasteride 13C6 is more potent than finasteride, and is able to inhibit both types of the 5-alpha-reductase enzyme, which is responsible for the conversion of testosterone to DHT.
In terms of chemical information, Dutasteride 13C6 has a molecular formula of C27H30F6N2O2, and a molecular weight of 528.54 g/mol. It is a white to pale yellow powder that is soluble in ethanol, methanol, and dimethyl sulfoxide (DMSO).
Overall, Dutasteride 13C6 is an effective medication for the treatment of BPH, and its chemical properties make it a potent inhibitor of the 5-alpha-reductase enzyme. However, as with all medications, it is important to consult with a healthcare professional before using Dutasteride 13C6, as it may have potential side effects and interactions with other medications.
Get an Instant Quote
Related Compounds
Dutasteride-d3 |